What Boomers Need to Know About Digestion;
Enzymatic Therapy’s CompleteGest®1
Renew targets special digestive issues
GREEN BAY, Wis. (Business Wire EON/PRWEB ) October 29, 2008 --
As people age, changes in the digestive tract make occasional digestive
issues more likely. In fact, nearly 70 million Americans have some sort
of digestive issue every year, and as many as 40% of older, boomer-aged
adults have one or more symptoms related to digestive concerns.
Enzymatic Therapy® has launched the answer
for baby boomers wondering what happened to their digestive systems –
CompleteGest1 Renew age-optimized enzymes.
Most boomers remember when they could eat whatever they wanted without
worrying about suffering any discomfort. There’s
a biological reason they can’t enjoy foods
the way they used to. According to Cheryl Myers, Vice President of
Health Sciences at Enzymatic Therapy, “As the
body ages, enzyme production is dramatically reduced, so you aren’t
able to break down foods as effectively as you once could. This leaves
people with occasional gas, discomfort and bloating after enjoying some
of their favorite foods.”
CompleteGest1 Renew is a new, proprietary
formula that goes above and beyond other digestion products on the
market. It’s custom-formulated to meet the
needs of people past their thirties, and designed to enhance the ability
to digest problematic foods including raw foods, fats, wheat and dairy.1
This breakthrough product helps the boomer generation say good-bye to
occasional digestive discomfort and rediscover the pleasure of eating –
at any age!1
CompleteGest1 Renew is the newest addition to
Enzymatic Therapy’s successful line of enzyme
products, and is available at natural food retailers nationwide.
For nearly 30 years, Enzymatic Therapy, Inc., (ETI) based in Green Bay,
Wisconsin, has been North America’s leading
manufacturer and distributor of dietary supplements and natural
medicines. ETI is an FDA-registered drug establishment and also a
certified organic processor. It was the first company to introduce
standardized Ginkgo biloba, glucosamine sulfate and botanical
standardization to the United States health market. The company’s
products and ingredients are collectively the subject of over 2,500
independent, peer-reviewed-published clinical trials and studies. For
more information, visit enzy.com.
1These statements have not been evaluated by
the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any
disease.
See the original story at: http://eon.businesswire.com/releases/completegest1_renew/green_bay/prweb1543824.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1Mb3ZlLUNyYXMtVGhpci1NYWduLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
